Resources
Read the latest publications on our technology and applications.
Drug Type
- Small Molecule/Tyrosine Kinase Inhibitors
- Adoptive Cell Therapies
- Antibody Dependent Cellular Cytotoxicity
- Checkpoint Inhibitors
- Cell Therapies
- Antibody Drug Conjugates
- Other
Cancer Type
- Lung
- Kidney
- Brain
- NSCLC
- HNSCC
- Renal
- Colorectal
- Bladder
- Other
Need Help?
Contact Us for support
May 11, 2021
STING Application Note
May 10, 2021
Benefits of Tumoroids for Oncology R&D – Whitepaper
May 10, 2021
Studying the Mechanism of Action of Tumor Immune Cells – Application Note
Jun 22, 2020
Employing ex vivo 3D-ScreenSM technology for the development of rational combinations of immune-oncology drugs in tumor organoids of fresh patient tissue
Jun 22, 2020
Optimization of checkpoint inhibitor-TKI combinations in renal cell carcinoma using an ex vivo 3D tumor organoid model of fresh patient tissue with intact TME
